Sanofi 20F 2014 Annual report | SNY Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: acP, adequacy, advent, Afghanistan, Afrezza, al, Alfort, Allerject, Alstom, aluminum, Amersham, amino, amyloid, Amyloidotic, analogue, anatagonist, andThe, anew, angiopoietin, ANSM, antidiabetic, Antiprotozoal, Aplenzin, Apleway, APOLLO, Ardelyx, Argentine, arrhythmic, arsenal, Asi, ASMD, assignee, augmented, Automotive, awaited, bacteraemia, ban, Barceloneta, Bassler, belief, BFSA, Bonnie, BP, Brandicourt, breakfast, BVBA, Cardiomyopathy, carfilzomib, cartridge, castration, CBD, Cdiff, CDRH, Celgene, CENCOEX, Centre, ceramide, chewable, Chi, Chicago, Cie, COMBO, Comit, compassionate, comunicated, confirmatory, contact, converged, coopting, crystallized, currenlty, Daiichi, deduced, Deerhaven, depth, designee, destroying, devaluation, dissatisfaction, downside, DRIRE, Dubai, DWG, Ebola, effervescent, Eligard, embarked, EoE, eosinophilic, epitope, EPM, eprinomectin, equine, erectile, ERT, Etat, Eudravigilance, eurozone, fastest, faute, febrile, Feline, FluQuadri, forfeited, Fresolimumab, FTFF, GAAP, GalNAc, Game, gastroenterology, Gastrogard, Globalpharma, glycoprotein, Gouvernement, granule, grave, grippal, Hall, Ho, honoraria, household, HQCB, HTA, Humalog, Humulin, hyperinflationary, IcyHot, IDC, IFPMA, Ilac, immunotherapy, Imovane, Importantly, incompatible, incumbent, inDeferred, industrialisation, infantile, inhaled, inhaler, inscription, inThe, irreversible, IRS, itemResearch, itemsOther, IU, Jean, Juvenile, KAEC, Kaleo, Kitasato, KK, Kron, Lancet, Lasix, lipid, lipoprotein, lispro, logo, LongRange, lourde, LP, male, Malmaison, mannkind, Margerie, marker, marketplace, MAT, maytansinoid, Medtronic, MEK, Methadone, microbiology, microwave, migration, milbemycin, milliardi, Minh, MirioPen, misconduct, ml, mounting, multicenter, Mumbai, musculoskeletal, mutated, myelin, MyoKardia, myostatin, Nagoya, nanoparticle, Nepal, nephrology, nerve, Neuropathy, neuroprotection, neutral, newNexGard, nose, nuanced, ofAmaryl, ofCompagnie, Officiel, ofLemtrada, ofNexGard, olipudase, Oliver, onNet, orOther, ou, oxime, pathology, Patrick, PCV, Pechiney, permission, permissive, peso, phosphoinositide, physicochemical, PJSC, PK, Planet, pomalidomide, ponazuril, pose, pourvoi, povidone, pragmatically, Praluent, pre, prefilled, pregnancy, preparatory, prequalified, Princeton, prioritization, prioritize, propelled, prorated, protozoal, PSUR, Purevax, quinoline, rDNA, reaction, reconfirmed, RecyCoal, referenced, refreshing, relabel, relocation, remyelination, Ren, repellent, repetition, RetinoStat, retrieval, retrieve, revusiran, risen, rival, RMS, roadmap, rollout, rouble, RP, RSV, Rueil, runny, RWG, sachet, Sanayi, sand, Saneca, Sankyo, SAR, SC, semisynthetic, sequence, SGBV, sheath, SICAD, SIMADI, simplicity, SK, SLE, SmartRelief, sneezing, SOLO, somatic, Sorbonne, SORELLA, speaking, Spectra, sphingomyelinase, steadily, sterile, straightforward, strictly, Sunshine, superseded, symptomatic, Syncytial, tadalafil, Takeda, teaching, theDirection, thefipronil, thehaut, Ticaret, tofogliflozin, Tolmar, Toujeo, toxicology, tubulin, UCB, ultrasound, unanimously, unilateral, unprecedent, unspecified, untreated, Unum, upside, urban, usability, Valeo, Vatelizumab, ve, versa, vital, vivo, VL, Vocal, voucher, watery, wave, weaken, whistleblower, worsen, wrote, younger

Removed: AAD, AAV, abundant, Acomplia, acutely, admission, affiliated, aid, aluminium, appraisal, authorisation, baby, beauty, Belfer, Benzaclin, bio, bleeding, blower, Bombardier, bought, bowel, BTV, buoyed, capsule, capture, Carac, Carticel, Chondrocyte, chronically, Cincinnati, clearer, compensatory, comptable, concealed, concentrating, contesting, convenient, Copaxone, corridor, critically, Crucell, DDAVP, deferral, depression, dermatology, Dermik, destined, DFCI, DLBCL, dosing, Douro, dramatically, Duke, Eloxatine, enjoining, enregistrement, Epicel, esthetic, FASB, Ferring, Flutter, formula, Forum, fowl, fragment, Fresolumimab, Fuqua, genomic, Goiter, GRC, Greylock, grower, Hanspeter, harmonize, henceforth, Humaneered, IKK, ill, Implantation, inequitable, inflammatory, iPhone, ix, JPY, jury, kill, Landgericht, landmark, LDL, lice, loan, Lord, lymphocyte, MACI, mandated, Manhattan, Maryland, menopause, Metabolex, meter, monopolize, Monsanto, NICE, node, Nord, Oenobiol, ofCopaxone, ofFondation, originated, outbreak, outset, pa, Parkinson, passively, path, Pernod, pillar, planed, pool, premature, Prevelle, proved, pursued, QIV, reallocated, recruitment, regain, Renault, repayment, requalification, resolving, restate, retroactive, retrospectively, Ricard, Riceland, Richemont, rimonabant, RIT, rituximab, Rochester, Rock, scrupulously, Sculptra, Seikagaku, Seine, seriousPa, Sherman, sized, skincare, sound, Spek, squeeze, substrate, sued, suicidality, surgery, taxed, tertiary, ticker, toPa, TROPIC, TRV, USD, vanilloid, vi, vii, viii, violation, VKA, VTE, Warp, WCRX, wellbeing, Wellcome, whistle, whointer, Wyeth, Zactran, Zimmer, Zimulti

	By:	/s/ Jérôme Contamine
		Jérôme Contamine
		Executive Vice President Chief Financial Officer (1)

Sanofi (SNY) 20-F2014 FY Annual report (foreign)

Content analysis